ANDERSON CYNTHIA LYNN (CHIEF FINANCIAL OFFICER) received a stock award from VISTAGEN THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/13/2025ACC: 0001415889-25-001396
Officer· CHIEF FINANCIAL OFFICER
Since Aug 2023
+2.59K
Net shares
Net buyer
$6.5K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
2.59K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+2.59K
Price / share
$2.51
Trade value
$6.50K
% of position
72.2%
12/31/2024
3.59K→6.18K
Total
Net shares
+2.59K
Net value
$6.50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/31/2024 | A · Award | +2.59K | $2.51 | $6.50K | 72.2% | 3.59K | 6.18K |
| Total | +2.59K | $6.50K | ||||||
Derivative Transactions0
No derivative transactions reported